Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation The Structural Heart Disease Summit 2018

How Should Physicians and Patients Choose Between Alternative Therapies for NVAF and Iatrogenic Stroke? The Essence of Shared Decision-making

Presenter: James B. Hermiller Jr, Saibal Kar, Megan Coylewright

June 23, 2018

Presentation TCT 2017

Case Study #3 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Case Study #3 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, David L. Tirschwell

November 01, 2017

Presentation TCT 2017

Case Study #2 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, Michael J. Mullen

November 01, 2017

Presentation TCT 2017

Case Study #2 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, Michael J. Mullen

November 01, 2017

Presentation TCT 2017

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

Case Study #1 Introduction: To Close or Not to Close?

Presenter: Lee N. Benson, Megan Coylewright, Steven L. Goldberg

November 01, 2017

Presentation TCT 2017

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation LAA 2017

LAA Closure: Shared Decision Making Criteria and Documentation

Presenter: Megan Coylewright

July 21, 2017

Presentation LAA 2017

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

Presenter: Megan Coylewright

July 21, 2017

Advertisement

TCTMD’s Top 10 Most Popular Stories for October 2023

How Should Physicians and Patients Choose Between Alternative Therapies for NVAF and Iatrogenic Stroke? The Essence of Shared Decision-making

Case Study #3 Resolution: How We Treated, and Long-term Outcome

Case Study #3 Introduction: To Close or Not to Close?

Case Study #2 Resolution: How We Treated, and Long-term Outcome

Case Study #2 Introduction: To Close or Not to Close?

Case Study #1 Resolution: How We Treated, and Long-term Outcome

Case Study #1 Introduction: To Close or Not to Close?

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

LAA Closure: Shared Decision Making Criteria and Documentation

Risk Scores and Biomarkers for Stroke and Bleeding: Applications and Recommendations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content